Sign in

Raza

@transfusion.health
355 followers 197 following 272 posts

🩸Physician + Researcher @UToronto. Medical decision-making, data science (stats, AI), films, and rock climbing #TMSky #Hemesky

PostsRepliesMedia
Raza @transfusion.health · 08/06/2026
In medical science, we do a terrible job of enabling non-physicians to do healthcare research There is no notion of protected research time, specific-grant funds, or recruiting their perspectives in the things we write Meanwhile non-physicians vastly outnumber physicians in healthcare provision
130
Reposted by Raza
Canadian Society for Transfusion Medicine @cstm-scmt.bsky.social · 04/06/2026
Quote of the morning from our AI workshop: if all you can do is prompt AI, then AI *will* take your job. @transfusion.health #cstm2026scmt #transusionmedicine #AIinmedicine
111
Raza @transfusion.health · 24/05/2026
I miss Mart Janssen. A brilliant data scientist and wonderful human. I still read his papers and miss him.
000
Raza @transfusion.health · 20/05/2026
Today I discovered Bradley-Terry, a very cool way to preserve information while analyzing data from multiple pairwise comparisons. I naively used to think multinomial regression would work here! #stats en.wikipedia.org/wiki/Bradley...
en.wikipedia.org
Bradley–Terry model - Wikipedia
000
Raza @transfusion.health · 08/04/2026
Survival analysis is among the most beautiful areas of biostats. As a clinician I am blown away by the ingenuity of concepts such as partial likelihoods, martingales, subdistributional hazards, transformation models. How many lives have been saved because we had the right tools for the job!? #stats
130
Raza @transfusion.health · 06/02/2026
Over-optimism for AI comes partly from the coincidence that the people developing it (coders) happen to perform the economic task it is the most adept at (coding). This creates a very strong self-reinforcing loop of hype and (imo) naive over-extrapolation of capabilities to other domains
010
Raza @transfusion.health · 27/01/2026
I find 'alpha spending' to be an incredibly awkward concept. How many hypotheses can I test? At what point does it stop being kosher? How much do I need to correct for multiple testing? How many tests can I run and how many I should just never test again? Is pre-specification the only answer? #stats
210
Raza @transfusion.health · 02/01/2026
One of the best pieces of advice I got as a doctor in training was to share my uncertainty and transparently lay out my thought process with patients. It goes against conventional wisdom that one may appear incompetent, unconfident, or indecisive. I've yet to meet a patient who didn't like it #meded
010
Raza @transfusion.health · 02/01/2026
If you have a statistician, ML engineer, or some similar methods expert on your project, give them commensurately high author line credit. They usually contribute far more and consequentially to studies than most other authors, yet often end up low middle-author or sometimes left off entirely #stats
010
Raza @transfusion.health · 26/12/2025
#ThePitt has been widely appraised for uncannily accurate dramatizations of emergency medicine. Pleased to report they've also done a great job with transfusion! www.trasci.com/article/S147... #medsky
trasci.com
“Go with O Pos” - Blood Transfusion During Mass - Casualty in The Pitt
Media depictions of blood transfusion are important because they can motivate blood donation, inform potential recipients, and shape public perceptions of the blood system. [1] Two-thirds of Americans...
051
Reposted by Raza
JAMA @jama.com · 09/12/2025
Among adults undergoing cardiac surgery at high risk of bleeding and platelet transfusion, cryopreserved platelets did not meet noninferiority for controlling postoperative bleeding and were less effective than liquid-stored platelets. #CCRdownunder ja.ma/4rEC06z
JAMA article titled 'Cryopreserved vs Liquid-Stored Platelets for the Treatment of Surgical Bleeding'. Key points: cryopreserved platelets may be less effective/safe than liquid-stored for cardiac surgery bleeding; didn't meet noninferiority criterion.
034
Raza @transfusion.health · 09/12/2025
The way the exponential form generalizes so many common, seemingly unrelated distributions (and all the properties you get for free, like sufficiency) has to be one of the most elegant things I’ve learned in #stats, and in general Good reader: brunomaga.github.io/Exponential-...
050
Raza @transfusion.health · 29/10/2025
In the era of evidence-based medicine, why do the similar patient face different treatment strategies at hospitals in the same healthcare system? We analyzed 800k+ admissions at 24 hospitals to examine transfusion practice at teaching and non-teaching hospitals link.springer.com/article/10.1...
link.springer.com
Red Cell Transfusion in General Medicine Patients at Teaching and Non-teaching Hospitals: A Retrospective Cohort Analysis - Journal of General Internal Medicine
Background Red blood cell transfusion is a well-studied intervention with numerous randomized trials to guide management, yet practice remains highly variable. Objective In this study, we explored hos...
020
Raza @transfusion.health · 26/10/2025
For those wrestling with applying MINT trial and new AABB RBC MI guidelines results with nuance, I think this figure strikes a good balance for navigating the evidence base at the bedside doi.org/10.1016/j.cj... #transfusion #medsky #cardiology
010
Raza @transfusion.health · 20/10/2025
A lot of people in healthcare are asking, "I want to use AI for [my field]" Higher yield: Let’s make a list of problems worth solving, then discuss if any are best addressed with AI (most won't be) (e.g. studies aren't typically motivated by, "I want to use retrospective cohort design")
010
Raza @transfusion.health · 18/10/2025
I think most people in the ML/AI space understand that, for most real-world uses, LLMs are merely the gateway drug to entice authority figures to invest in resources that will enable more reliable analytical ML systems. Kind of like how the WWF uses pandas to fund saving other endangered species
000
Reposted by Raza
Brian D. Adkins @path-brian.bsky.social · 06/10/2025
How are you diagnosing and treating mixed AIHA? pmc.ncbi.nlm.nih.gov/articles/PMC...
011
Raza @transfusion.health · 11/10/2025
Profiting from selling unproven therapies to desperate patients is as old as time. Why does it persist? Co-authors discuss antecedents, consequences, and contemporary examples of medical grifting from #transfusion, #hematology, and biotherapies onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Confronting medical grifting: Fraudulent and unproven products and interventions in apheresis, transfusion and biotherapies
A basic overview of medical grifting for haematologists with practical guidance in identification and tips for management.
010
Raza @transfusion.health · 08/10/2025
I was a programmer before I was a data analyst, and so have a toxic trait of jumping to nested loops for problems where dataframe transformation would be far more elegant. I can't possibly be alone? #stats #ML
250
Raza @transfusion.health · 22/09/2025
Classic teaching is that no post-1 hr increment points to immune refractoriness. One important exception is device-related failures, e.g. plts going into a clotted line, a faulty dialysis/apheresis circuit, an ECMO machine, etc! #hemesky #transfusion
040
Raza @transfusion.health · 18/09/2025
What is the current state of AI/ML research in transfusion medicine? Co-authors Na Li, @ruchika_goel1, et al, have compiled a critical summary of research applying AI/ML in transfusion, including some glossary tables lay readers will helpful Read here: www.sciencedirect.com/science/arti...
sciencedirect.com
Artificial Intelligence and Machine Learning in Transfusion Practice: An Analytical Assessment
Transfusion medicine is vital to healthcare and affects clinical outcomes, patient safety, and system resilience while addressing challenges such as b…
010
Raza @transfusion.health · 08/09/2025
My progression as a reader of scientific literature can be summarized by the first sections I read when I pick up an article High school: Abstract → Conclusion Undergrad: Abstract → Introduction Medical school: Abstract → Discussion Postgraduate: Abstract → Results Now: Abstract → Methods #medsky
111
Raza @transfusion.health · 07/09/2025
Can we improve the way we transfuse plasma? Yes. Big gaps. E.g the ineffectual practice of 1-2 plasma unit dosing is widespread, accounting for 4/5ths of all orders Study from our group now out in @aabbupdates.bsky.social journal onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Plasma transfusion practice: A five‐year audit of plasma transfusion at 23 hospitals
Background There is limited high-quality evidence to guide plasma transfusion, and plasma transfusion practices remain variable. Study design and methods This is a retrospective cohort study that ...
010
Raza @transfusion.health · 04/09/2025
Fancy health AI tool/models have to produce *some* real-world healthcare benefit on one of 5 core health outcomes: 1. Death 2. Disease = occurrence/severity/complications 3. Discomfort = phys/emotional 4. Disability = functional impact 5. Destitution (cost to individual/system) #ai #mlsky #medsky
001
Raza @transfusion.health · 29/08/2025
I believe when working with big data for causal inference, you HAVE to pre-specify your analyses (esp within a project). Do it for yourself, not for reviewers. As Feynman said, “[in science] the first principle is that you must not fool yourself and you are the easiest person to fool” #stats
061
Reposted by Raza
REBEL EM @rebel-em.bsky.social · 26/08/2025
🧪 ICARUS-ED: Early albumin in sepsis? 📉 Minor gains in numbers, no real outcome benefit 💰 30x the cost vs crystalloids ⚠️ Outcomes > optics 🔍 Full breakdown: wp.me/pdrP8b-5oc ❤️ Like 🔁 Repost 🔔 Follow for more #FOAMed #MedX #MedTwitter #MedEd
031
Raza @transfusion.health · 26/08/2025
“This trial adds to the growing body of evidence suggesting no clinically meaningful benefit to albumin administration in the resuscitation of septic patients”
011
Raza @transfusion.health · 18/08/2025
We need trials of AI showing better patient important outcomes (I'm not aware of any) #AI #ML #medsky
051
Raza @transfusion.health · 14/08/2025
Seeing a lot of PCC use in liver disease lately. What why how #hemesky #medsky
000
Raza @transfusion.health · 01/08/2025
Why do most hospitals have vending machines full of junk food but not a gym? #medsky
000
Raza @transfusion.health · 26/07/2025
You can tell if the person in your machine learning course has a math, stats, or compsci background by the quirky way they write code #ML #stats
000
Raza @transfusion.health · 14/07/2025
If you still use 5% IV albumin outside of PLEX, why? #medsky
110
Raza @transfusion.health · 28/06/2025
Canadian Blood Services data show rising demand for blood, reflected in increasing per-admission blood use in Canadian hospital databases. This is concerning as baby boomers are aging out of the donor pool, and zoomers are not replacing their numbers. onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Rising transfusion rates amidst stable blood supply: A Canadian perspective on emerging challenges for blood operators
Click on the article title to read more.
000
Reposted by Raza
Jacob Pendergrast @jacobpendergrast.bsky.social · 19/06/2025
June 19th is World Sickle Cell Awareness Day. Below is a link to a good review article on the subject, and in this thread are my two wishes as a physician who treats the condition: www.healthaffairs.org/content/fore...
healthaffairs.org
Beyond Gene Therapies: People With Sickle Cell Disease Need Comprehensive Care | Health Affairs Forefront
We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.
101
Raza @transfusion.health · 18/06/2025
Blood is shared across legal borders to save lives. Equitable and efficient movement of blood is guided by science and justice and must be insulated from ideologically motivated practices, argue co-authors @jwjacobs12.bsky.social @aabbupdates.bsky.social onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Blood Borders: State laws, vaccine misinformation, and the threat to the United States blood supply
Click on the article title to read more.
022
Raza @transfusion.health · 14/06/2025
I was today years old when I finally saw this masterpiece, which is an embarrassing confession as a movie buff. Absolutely blown away by the writing and pacing #filmsky
030
Raza @transfusion.health · 12/06/2025
The ALBICS trial is a humbling reminder that no matter how elegant physiologic reasoning may be, we need real-world experiments to know whether transfusion will benefit patients jamanetwork.com/journals/jam... #nephrology #transfusion
jamanetwork.com
Albumin Infusion and Kidney Injury in Cardiac Surgery Patients
This randomized clinical trial evaluates the use of postoperative 20% albumin infusion vs usual care in high-risk cardiac surgery patients.
000
Reposted by Raza
Jeremy Jacobs, MD, MHS, FASCP @jwjacobs12.bsky.social · 23/05/2025
In this Nature Medicine commentary @drgsbooth1.bsky.social and I discuss how the current political environment in the USA, including the weaponization of immigration enforcement, is impacting global scientific research, and the implications for science. www.nature.com/articles/s41...
nature.com
How US politics is undermining global science
Nature Medicine - How US politics is undermining global science
011
Raza @transfusion.health · 22/05/2025
I know there are many more sophisticated uses for causal inference, but DAGs are just straight up awesome for brainstorming study questions and thinking through models #stats #causalinference #statsky
080
Raza @transfusion.health · 20/05/2025
Mixed Autoimmune Hemolytic Anemia is a fascinating and challenging disease of blood breakdown via multiple immune pathways Our systematic review summarizes what is currently known about features and outcomes of patients with this condition onlinelibrary.wiley.com/doi/10.1002/... #hemesky #medsky
onlinelibrary.wiley.com
Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes
Mixed autoimmune hemolytic anemia (AIHA) is a rare condition characterized by the presence of both warm and cold autoantibodies, often leading to severe, treatment-resistant hemolysis. In this system...
010
Raza @transfusion.health · 18/05/2025
People who are MD + PhDs What would make you advise someone to do PhD or MD first? #medsky
000
Reposted by Raza
Jeremy Jacobs, MD, MHS, FASCP @jwjacobs12.bsky.social · 14/05/2025
🩸Would you want “unvaccinated” blood? Some patients now demand it—and lawmakers are listening. Our new Annals piece warns why this shift could endanger blood safety, amplify misinformation, and erode public trust. Read: www.acpjournals.org/doi/10.7326/... #BloodSafety #Bioethics #Misinformation
acpjournals.org
Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025 | Annals of Internal Medicine
In the United States and other high-income countries, blood donation primarily relies on anonymous, voluntary donors. However, directed blood donation—where people donate for a specific recipient—has ...
123
Raza @transfusion.health · 13/05/2025
Is directed blood donation (donation earmarked for a specific recipient) ethically or medically justified? In @annalsofim.bsky.social, my co-authors argue that in the vast majority of clinical situations, the answer is no www.acpjournals.org/doi/10.7326/...
acpjournals.org
Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025 | Annals of Internal Medicine
In the United States and other high-income countries, blood donation primarily relies on anonymous, voluntary donors. However, directed blood donation—where people donate for a specific recipient—has ...
010
Raza @transfusion.health · 12/05/2025
Proud to have contributed to OpenAI's #Healthbench, alongside physicians from around the world. This was a unique opportunity to evaluate how AI performs on real health challenges and help shape how we measure progress. Learn more: openai.com/index/health...
openai.com
Introducing HealthBench
HealthBench is a new evaluation benchmark for AI in healthcare which evaluates models in realistic scenarios. Built with input from 250+ physicians, it aims to provide a shared standard for model perf...
100
Raza @transfusion.health · 07/05/2025
Does anyone know a good educational resource on federated learning? Can be lectures, books, etc (no research papers... I am not there yet) #stats
000
Raza @transfusion.health · 03/05/2025
Can we rationalize the way we give diuretic prophylaxis before transfusion? Colleagues @uhntoronto.bsky.social incl talented co-fellow Dr. Rotin and @jacobpendergrast.bsky.social have made a substantial stride in dose modelling to target urine output onlinelibrary.wiley.com/doi/pdf/10.1... #medsky
011
Raza @transfusion.health · 24/04/2025
#NATA2025 The side for liberal hemoglobin transfusion thresholds make their case for MI and neurological injury #medsky
010
Raza @transfusion.health · 24/04/2025
Viscoelastic Testing in Post-Partum Hemorrhage Potentially useful, understudied HYPOcoagulability is important as well described HYPERcoagulability is also important, poorly studied #NATA25 #medsky #transfusion #obgyn
000
Raza @transfusion.health · 24/04/2025
Intravenous Iron at Home Dr. Elvira Bibs, reports on the Spanish experience Better for older patients, saves hospital beds, gives a high need treatment. Takeaway: select the right patients. Mind the logistics "What is lacking? Courage to implement it" #NATA25 #hemesky #medsky #transfusion
010
Raza @transfusion.health · 24/04/2025
Great talk to start off #NATA2025 by Dr. Paul Kalra, the investigator on IRONMAN trial for iron replacement in CHF → Patients feel better, and do better, with greater benefit in TSat >20% → No signal for increased infection related death No brainer! #medsky #hemesky #cardiology
000